Difference between revisions of "HAN5:Volunteer Assignments and Opportunities"
Jump to navigation
Jump to search
[checked revision] | [checked revision] |
(10 intermediate revisions by the same user not shown) | |||
Line 300: | Line 300: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 3 (NASOPHARYNGEAL TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[HAN5:Hairy_polyp|Hairy polyp]] | |[[HAN5:Hairy_polyp|Hairy polyp]] | ||
Line 344: | Line 364: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 4 (HYPOPHARYNGEAL, LARYNGEAL, TRACHEA, AND PARAPHARYNGEAL TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[HAN5:Squamous_papilloma_and_papillomatosis|Squamous papilloma and papillomatosis]] | |[[HAN5:Squamous_papilloma_and_papillomatosis|Squamous papilloma and papillomatosis]] | ||
Line 454: | Line 494: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 5 (SALIVARY GLAND TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[HAN5:Nodular_oncocytic_hyperplasia|Nodular oncocytic hyperplasia]] | |[[HAN5:Nodular_oncocytic_hyperplasia|Nodular oncocytic hyperplasia]] | ||
Line 884: | Line 944: | ||
| | | | ||
|- | |- | ||
− | |[[HAN5:Necrotizing_sialometaplasia|Necrotizing sialometaplasia]] | + | |CHAPTER 6 (ORAL CAVITY AND MOBILE TONGUE TUMOURS) |
− | |Disease | + | | |
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | |- | ||
+ | |[[HAN5:Necrotizing_sialometaplasia|Necrotizing sialometaplasia]] | ||
+ | |Disease | ||
| | | | ||
| | | | ||
Line 1,059: | Line 1,139: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 7 (OROPHARYNGEAL TUMOURS (BASE OF TONGUE, TONSILS, ADNOIDS)) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[HAN5:Hamartomatous_polyps|Hamartomatous polyps]] | |[[HAN5:Hamartomatous_polyps|Hamartomatous polyps]] | ||
Line 1,092: | Line 1,192: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 8 (ODONTOGENIC AND MAXILLOFACIAL BONE TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[HAN5:Radicular_cyst|Radicular cyst]] | |[[HAN5:Radicular_cyst|Radicular cyst]] | ||
Line 1,698: | Line 1,818: | ||
| | | | ||
|- | |- | ||
− | |[[HAN5:Chondrodermatitis_nodularis_chronica_helicis|Chondrodermatitis nodularis chronica helicis]] | + | |CHAPTER 9 (EAR TUMOURS) |
− | |Disease | + | | |
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | |- | ||
+ | |[[HAN5:Chondrodermatitis_nodularis_chronica_helicis|Chondrodermatitis nodularis chronica helicis]] | ||
+ | |Disease | ||
| | | | ||
| | | | ||
Line 1,851: | Line 1,991: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 10 (SOFT TISSUE TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[HAN5:Lipomas|Lipomas]] | |[[HAN5:Lipomas|Lipomas]] | ||
Line 2,203: | Line 2,363: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 11 (HAEMATOLYMPHOID PROLIFERATIONS AND NEOPLASIA) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[HAN5:Reactive_lymphoid_hyperplasia|Reactive lymphoid hyperplasia]] | |[[HAN5:Reactive_lymphoid_hyperplasia|Reactive lymphoid hyperplasia]] | ||
Line 2,445: | Line 2,625: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 12 (MELANOCYTIC TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[HAN5:Mucosal_melanoma|Mucosal melanoma]] | |[[HAN5:Mucosal_melanoma|Mucosal melanoma]] | ||
Line 2,456: | Line 2,656: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 13 (TUMOURS AND TUMOUR-IIKE LESIONS OF THE NECK AND LYMPH NODES) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[HAN5:Ranula|Ranula]] | |[[HAN5:Ranula|Ranula]] | ||
Line 2,545: | Line 2,765: | ||
| | | | ||
|- | |- | ||
− | | | + | |CHAPTER 14 (GERM CELL TUMOURS) |
− | + | | | |
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
|- | |- | ||
− | |[[HAN5: | + | |[[HAN5:Germ_cell_tumours_of_the_head_and_neck|Germ cell tumours of the head and neck]] |
|Disease | |Disease | ||
| | | | ||
Line 2,567: | Line 2,796: | ||
| | | | ||
|- | |- | ||
− | | | + | |CHAPTER 15 (METASTASIS) |
− | + | | | |
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
|- | |- | ||
− | |[[HAN5: | + | |[[HAN5:Metastases_to_the_head_and_neck_region|Metastases to the head and neck region]] |
|Disease | |Disease | ||
| | | | ||
Line 2,589: | Line 2,827: | ||
| | | | ||
|- | |- | ||
− | | | + | |CHAPTER 16 (NEUROENDOCRINE NEOPLASMS AND PARAGANGLIOMA) |
− | + | | | |
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
|- | |- | ||
− | |[[HAN5: | + | |[[HAN5:Neuroendocrine_tumour|Neuroendocrine tumour]] |
|Disease | |Disease | ||
| | | | ||
Line 2,611: | Line 2,858: | ||
| | | | ||
|- | |- | ||
− | |[[HAN5: | + | |[[HAN5:Ectopic_or_invasive_PitNET_/_pituitary_adenoma|Ectopic or invasive PitNET / pituitary adenoma]] |
|Disease | |Disease | ||
| | | | ||
Line 2,622: | Line 2,869: | ||
| | | | ||
|- | |- | ||
− | |[[HAN5: | + | |[[HAN5:Small_cell_neuroendocrine_carcinoma|Small cell neuroendocrine carcinoma]] |
|Disease | |Disease | ||
| | | | ||
Line 2,633: | Line 2,880: | ||
| | | | ||
|- | |- | ||
− | |[[HAN5: | + | |[[HAN5:Large_cell_neuroendocrine_carcinoma|Large cell neuroendocrine carcinoma]] |
|Disease | |Disease | ||
| | | | ||
Line 2,644: | Line 2,891: | ||
| | | | ||
|- | |- | ||
− | |[[HAN5: | + | |[[HAN5:Merkel_cell_carcinoma|Merkel cell carcinoma]] |
|Disease | |Disease | ||
| | | | ||
Line 2,655: | Line 2,902: | ||
| | | | ||
|- | |- | ||
− | |[[HAN5: | + | |[[HAN5:Head_and_neck_paraganglioma|Head and neck paraganglioma]] |
|Disease | |Disease | ||
| | | | ||
Line 2,666: | Line 2,913: | ||
| | | | ||
|- | |- | ||
− | | | + | |CHAPTER 17 (GENETIC TUMOUR SYNDROMES INVOLVING THE HEAD AND NECK) |
− | + | | | |
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
|- | |- | ||
− | |[[HAN5: | + | |[[HAN5:Naevoid_basal_cell_carcinoma_syndrome_(Gorlin_syndrome)|Naevoid basal cell carcinoma syndrome (Gorlin syndrome)]] |
|Disease | |Disease | ||
| | | | ||
Line 2,688: | Line 2,944: | ||
| | | | ||
|- | |- | ||
− | |[[HAN5: | + | |[[HAN5:Neurofibromatosis_type_1|Neurofibromatosis type 1]] |
+ | |Disease | ||
+ | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |- | ||
+ | |[[HAN5:Familial_adenomatous_polyposis_and_Gardner_syndrome|Familial adenomatous polyposis and Gardner syndrome]] | ||
+ | |Disease | ||
+ | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |- | ||
+ | |[[HAN5:Brooke-Spiegler_syndrome|Brooke-Spiegler syndrome]] | ||
|Disease | |Disease | ||
| | | | ||
Line 2,699: | Line 2,977: | ||
| | | | ||
|- | |- | ||
− | |[[HAN5: | + | |[[HAN5:Cowden_syndrome|Cowden syndrome]] |
+ | |Disease | ||
+ | |[[DIG5:Volunteer Assignments and Opportunities|See DIG5 volunteer sheet for authorship status]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |- | ||
+ | |[[HAN5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]] | ||
|Disease | |Disease | ||
| | | | ||
Line 2,709: | Line 2,998: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |[[HAN5:Multiple_endocrine_neoplasia_type_2|Multiple endocrine neoplasia type 2]] | ||
+ | |Disease | ||
+ | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
|- | |- | ||
|[[HAN5:Hyperparathyroidism-jaw_tumour_syndrome|Hyperparathyroidism-jaw tumour syndrome]] | |[[HAN5:Hyperparathyroidism-jaw_tumour_syndrome|Hyperparathyroidism-jaw tumour syndrome]] | ||
Line 2,723: | Line 3,023: | ||
|[[HAN5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]] | |[[HAN5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | |- | + | |- |
|[[HAN5:Fanconi_anaemia|Fanconi anaemia]] | |[[HAN5:Fanconi_anaemia|Fanconi anaemia]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[HAN5:Dyskeratosis_congenita|Dyskeratosis congenita]] | |[[HAN5:Dyskeratosis_congenita|Dyskeratosis congenita]] | ||
Line 2,756: | Line 3,056: | ||
|[[HAN5:Ataxia-telangiectasia|Ataxia-telangiectasia]] | |[[HAN5:Ataxia-telangiectasia|Ataxia-telangiectasia]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[HAN5:Bloom_syndrome|Bloom syndrome]] | |[[HAN5:Bloom_syndrome|Bloom syndrome]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[HAN5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]] | |[[HAN5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[HAN5:Tuberous_sclerosis|Tuberous sclerosis]] | |[[HAN5:Tuberous_sclerosis|Tuberous sclerosis]] |
Revision as of 16:40, 15 July 2024
Welcome!
For assignments, please see the "Author" column below (highlighted blue).
If empty (no name is present), please volunteer to create content for that disease!
To volunteer, please [Contact us] with your page of interest.